Global Conference 2010
David Brennan is CEO of AstraZeneca, based at its global headquarters in London. Before becoming CEO in 2006, Brennan was president and CEO of AstraZeneca LP, the company's North American subsidiary. He was appointed director of the executive board of AstraZeneca in 2005. Brennan joined AstraMerck in 1992, helping to build the joint venture into a multi-billion-dollar business in the U.S. before a merger in 1999 formed AstraZeneca. Previously, Brennan worked in sales and marketing management in Merck's U.S. and international divisions. He also serves as chairman of the board of the Pharmaceutical Research and Manufacturers of America; a member of the executive board of the European Federation of Pharmaceutical Industries and Associations; and a member of the European Roundtable of Industrialists, among other organizations. He has a degree in business administration from Gettysburg College.